CANDEL THERAPEUTICS INC CADL
COM · Common Stock · CUSIP 137404109
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersNeedham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($2.0k this quarter). Holder counts are more reliable. Shares outstanding: 28.9m as of 2022-07-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $3.24.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 13 |
| Q4 2021 | 21 |
| Q1 2022 | 24 |
| Q2 2022 | 24 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 13 | 3 |
| Q1 2022 | 11 | 8 |
| Q2 2022 | 7 | 11 |
Biggest buyers
| Point72 Asset Management, L.P. | New | +743.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Added | +57.7k |
| UBS Group AG | Added | +1.8k |
| Tower Research Capital LLC (TRC) | Added | +1.2k |
| NORTHERN TRUST CORP | Added | +1.0k |
| Point72 Hong Kong Ltd | New | +640 |
| WELLS FARGO & COMPANY/MN | New | +61 |
Biggest sellers
| FMR LLC | Reduced | -1.1m |
| 683 Capital Management, LLC | Sold out | -40.9k |
| D. E. Shaw & Co., Inc. | Sold out | -10.9k |
| BlackRock Inc. | Reduced | -2.9k |
| JPMORGAN CHASE & CO | Reduced | -2.1k |
| VANGUARD GROUP INC | Reduced | -1.7k |
| BANK OF AMERICA CORP /DE/ | Reduced | -1.3k |
| GOLDMAN SACHS GROUP INC | Reduced | -473 |
| High Net Worth Advisory Group LLC | Sold out | -300 |
| CITIGROUP INC | Reduced | -180 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| FMR LLC 13G · institution +5.7 pts · filed 2025-02-07 | 15.0% |
| RTW INVESTMENTS, LP 13G · institution new · filed 2026-05-15 | 8.8% |
| Manning Paul B 13D · may seek influence filed 2026-03-18 | 7.9% |
| BlackRock, Inc. 13G · institution +2.4 pts · filed 2026-07-27 | 6.6% |
| ACORN BIOVENTURES, L.P. 13G · passive investor new · filed 2025-06-30 | 5.2% |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 6 | $14.8m | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Northpond Ventures, LLC 5.97% of their portfolio | 1.9m $6.3m | Unchanged |
| FRANKLIN RESOURCES INC 0.00% of their portfolio | 1.1m $3.6m | Unchanged |
| FMR LLC 0.00% of their portfolio | 899.4k $2.9m | Reduced -1.1m |
| Sands Capital Alternatives, LLC 0.72% of their portfolio | 811.7k $2.6m | Unchanged |
| Point72 Asset Management, L.P. 0.01% of their portfolio | 743.1k $2.4m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 405.5k $1.3m | Reduced -1.7k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 132.7k $430.0k | Added +57.7k |
| BlackRock Inc. 0.00% of their portfolio | 129.4k $420.0k | Reduced -2.9k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 75.2k $243.0k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 27.6k $89.0k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 14.5k $47.0k | Added +1.0k |
| Kestra Advisory Services, LLC 0.00% of their portfolio | 12.5k $41.0k | Unchanged |
| Empirical Asset Management, LLC 0.04% of their portfolio | 12.0k $39.0k | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 10.0k $33.0k | Reduced -473 |
| MORGAN STANLEY 0.00% of their portfolio | 4.6k $15.0k | Reduced -30 |
| UBS Group AG 0.00% of their portfolio | 3.8k $12.0k | Added +1.8k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 1.2k $4.0k | Reduced -2.1k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.2k $4.0k | Added +1.2k |
| Point72 Hong Kong Ltd 0.00% of their portfolio | 640 $2.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 430 $1.0k | Reduced -180 |
| Quent Capital, LLC 0.00% of their portfolio | 182 $1.0k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 150 $0 | Reduced -1.3k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 61 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |